Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk ...

A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and neck squamous cell ...

In fact, 25 percent of cervical cancer diagnoses occur in women over the age of 65, and cervical cancers diagnosed in this ...

Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or ...

CHENNAI: Tina Knowles—renowned American businesswoman, fashion designer, and perhaps most affectionately known as the mother ...

Dose optimization and RP2D determination on schedule for completion in Q4 2025 for the Nectin-4 ADC CRB-701 in HNSCC, ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), and cervical cancer patients for treatment with KEYTRUDA. Consequently, PD-L1 IHC 22C3 pharmDx is labeled for ...

including a cancer of the cervix and vagina called clear cell adenocarcinoma, as well as cervical precancers. It’s a good idea to talk to your doctor if you have any of those factors about how ...

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that a poster presentation of preclinical data of CS2009 ...